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Abstract
Ascorbic acid has been reported to extend replicative life span of human embryonic fibroblast (HEF). Since the detailed molecular mechanism
of this phenomenon has not been investigated, we attempted to elucidate. Continuous treatment of HEF cells with ascorbic acid (at 200 μM) from
40 population doubling (PD) increased maximum PD numbers by 18% and lowered SA-β-gal positive staining, an aging marker, by 2.3 folds, indicating
that ascorbic acid extends replicative life span of HEF cells. Ascorbic acid treatment lowered DCFH by about 7 folds and Rho123 by about 70%,
suggesting that ascorbic acid dramatically decreased ROS formation. Ascorbic acid also increased aconitase activity, a marker of mitochondrial aging,
by 41%, indicating that ascorbic acid treatment restores age-related decline of mitochondrial function. Cell cycle analysis by flow cytometry revealed
that ascorbic acid treatment decreased G1 population up to 12%. Further western blot analysis showed that ascorbic acid treatment decreased levels
of p53, phospho-p53 at ser 15, and p21, indicating that ascorbic acid relieved senescence-related G1 arrest. Analysis of AP (apurinic/apyrimidinic)
sites showed that ascorbic acid treatment decreased AP site formation by 35%. We also tested the effect of hydrogen peroxide treatment, as an
additional oxidative stress. Continuous treatment of 20 μM of hydrogen peroxide from PD 40 of HEF cells resulted in premature senescence due
to increased ROS level, and increased AP sites. Taken together, the results suggest that ascorbic acid extends replicative life s p a n  o f  H E F  c e l l s
by reducing mitochondrial and DNA damages through lowering cellular ROS.
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Introduction5)
Replicative senescence is an irreversible growth arrest of 
primary cells in culture system. It has been reported that aging 
in vivo is related to the limited replicative capacity that normal 
somatic cells show in vitro (Hayflick & Moorhea, 1961). 
Telomere shortening theory has been linked to replicative 
senescence (Campisi, 2001). Absence of telomerase in somatic 
cells causes the progressive shortening of telomeric DNA. This 
erosion eventually destroys telomere integrity and triggered 
senescence by activating DNA damage checkpoints that block 
further cell division (Smogorzewska & de Lange, 2002). 
However, it has been reported that many stimuli, including DNA 
damage and oxidative stress, result in cells to arrest growth with 
a senescent phenotype, independent of telomere length (Fagagna 
et al., 2003; Gorenne et al., 2006; Petersen et al., 1998; Sharma 
et al., 2006). Since other than human primary somatic cells like 
mouse and dog fibroblast cells are known to contain telomerase 
activity and longer telomeres, telomere shortening theory can not 
apply to other mammalian somatic cells.
Increasing number of evidence, mostly from work in 
fibroblasts, indicates that oxidative stress can also induce 
replicative senescence (Serrano & Blasco, 2001). Reactive 
oxygen species (ROS) produced during oxidative phosphory-
lation in mitochondria attack cellular macromolecules and 
produce oxidized protein, lipid and DNA products. Damaged 
macromolecules are accumulated with age in animal cells 
(Hamilton  et al., 2001; Levine et al., 2002; Pamplona et al., 
2000). High levels of oxidized cellular macromolecules have 
been reported to be correlated with shorter life spans in mammals 
(Barja & Herrero, 2000). Cultivation of fibroblast in lower 
oxygen, instead of atmospheric oxygen resulted in delaying of 
replicative senescence, indicating that oxidative stress contributes 
to replicative senescence (Parrinello et al., 2003).
Ascorbic acid is an antioxidant that can protect cells from 
oxidative stress. When ascorbic acid was treated in hydrogen 
peroxide-treated human dermal fibroblast cells, ascorbic acid 
protected the hydrogen peroxide-driven oxidative damage. 
Ascorbic acid has also been reported to prevent damage of 
cellular macromolecules including lipid, protein, and DNA 
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(Amer, 2002; Carty et al., 2000; Huang et al., 2002; Lenton et 
al., 1999) and incidence of certain cancers (Chen et al., 1988). 
However, life-long ascorbic acid supplementation has shown 
controversial effects in animal studies. A life-long supplemen-
tation of ascorbic acid or mixed antioxidants in the drinking water 
of mice was reported to increase mean life span significantly 
(Massie  et al., 1984; Veurink et al., 2003). But a mixed 
antioxidant diet had no effect on life span of rats (Holloszy, 1998; 
Selman et al., 2006). Ascorbic acid also resulted in the extension 
of replicative life span in human diploid fibroblast culture. The 
extension of life span was accompanied by reducing the rate of 
telomere shortening (Farriol et al., 1994; Kashino et al., 2003; 
Levine, 2002). However, the detailed molecular mechanism other 
than telomere shortening has not been investigated. In this paper, 
we attempted to elucidate how ascorbic acid extends replicative 
life span of HEF cells. Here, we showed that ascorbic acid 
postponed replicative senescence of human fibroblast by reducing 
mitochondrial and DNA damages through scavenging ROS.
Materials and Methods
Cell culture and cell cycle analysis
A primary human embryonic fibroblast (HEF) that was 
established from an abortus at Hallym University Hospital was 
obtained (Kim et al., 2005) and used for this work. Human 
embryonic fibroblasts were grown in DMEM supplemented with 
10% FBS at 37℃ with humidified atmosphere containing 5% 
CO2. The primary culture was designated as zero of PD number. 
HEF cells were cultivated continuously until replicative 
senescence by splitting cells (at 1:4 splitting rate) every 3-6 days 
and the media were replaced every 3-4 days. HEF cells were 
treated continuously with various concentrations of ascorbic acid 
from PD 40 and measured the maximum PD number to test the 
extension of PD. Since it was reported that blood Vitamin C 
level maintained at 24 μM and oral supplementation of Vitamin 
C increased blood Vitamin C level, ascorbic acid was treated 
at 2, 20, and 200 μM (Fumeron et al., 2005). Plating efficiency 
was analyzed by counting the number of floating cells 1 day 
after splitting to calculate correct PD numbers. For cell cycle 
analyses, 2 × 10
6 cells were harvested by trypsinization and fixed 
by cold 70% ethanol. After fixation at -20℃ for 4 hr, cells were 
collected and subsequently resuspended in staining solution (50 
µg/mL propidium iodide, 50 µg/mL RNase A), and subjected 
to FACScan analysis using a FACS Vantage flow cytometer. 
Experiments were repeated more than three times to confirm the 
result.
SA-β-gal staining
Senescence associated-β-galactosidase (SA-β-gal) activity was 
determined by the procedure described previously (Dimri et al., 
1995). HEF cells were washed with 1 × PBS and then fixed with 
2% formaldehyde in PBS for 5 min. Cells were washed again 
two times with PBS and then mixed with staining solution (1 
mg/mL X-gal, 40 mM citric acid/sodium phosphate (pH 6.0), 
5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 
mM NaCl, 2 mM MgCl2) and incubated at 37℃ for 18 hr. After 
incubation, the percentage of stained cells was counted under 
the microscope. Average value and standard deviation calculated 
from more than three repeats of experiment were used.
Measurement of ROS level and age-dependent mitochondrial 
damage by fluorometer
The level of cellular ROS was measured through fluorometric 
detection of DCFH (2′, 7′-dichlorodihydrofluorescin) oxidation 
induced by ROS. Age-dependent mitochondrial damage was 
measured through fluorometric detection of Rho123 (dihydror-
hodamine 123). Cells were incubated with 10 µM DCFH at 37℃ 
for 10 min. They were then washed twice with PBS, and lysed 
with lysis buffer [10 mM Tris-HCl buffer (pH 7.4) containing 
0.5% Tween 20]. Cell debris was removed by centrifugation at 
10,000 × g for 10 min. DCF fluorescence of the supernatant was 
measured using a spectrofluorometer with excitation of 500 nm 
and emission by scanning from 500 to 550 nm. Accumulation 
of Rho123 in mitochondria was measured with excitation at 500 
nm and emission at 536 nm. Average value and standard 
deviation calculated from more than three repeats of experiment 
were used.
Analysis of aconitase activity
Aconitase activity was determined as described (Liang et al., 
1997). 4 × 10
6 cells were incubated in ice-cold reaction buffer 
[50 mM Tris (pH 7.4), 0.6 mM MnCl2, 20 mM fluorocitrate] 
containing a mixture of protease inhibitors (5 μg/mL leupeptin, 
5 μg/mL aprotinin, and 1 mM PMSF) and disrupted by sonication 
with three bursts of 5 seconds on ice. After centrifugation, the 
supernatant was used for measuring total soluble protein. 
Aconitase activity was determined spectrophotometrically as 
described previously (Levine, 1997). Average value and standard 
deviation calculated from more than three repeats of experiment 
were used.
Western blot analysis
HEF cells were harvested, washed in PBS, and lysed with 
extraction buffer [50 mM Tris-Cl (pH 7.4), 150 mM NaCl, 5 
mM EDTA (pH 8.0), 1% NP-40] containing a mixture of protease 
inhibitors (1 mM PMSF, 5 μg/mL aprotinin, 5 μg/mL leupeptin). 
After centrifugation, the protein concentration of the supernatants 
was determined using BCA protein assay reagent (Pierce). The 
proteins were loaded on a 10% or 12% SDS-PAGE gel and 
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Table 1. The extension of maximum PD number in ascorbic acid-treated HEF 
cells compared to untreated cells. HEF cells were cultivated continuously in the
presence of different concentrations of ascorbic acid until replicative senescence
and the maximum PD number was counted.
Treatment Population Doublings
200  μM ascorbic acid 73 ± 2.5
20  μM ascorbic acid 68 ± 1.5
2  μM ascorbic acid 64 ± 1.5
untreated 62 ± 1.5
Fig. 1. The effect of ascorbic acid on growth and replicative life span of human 
embryonic fibroblast (HEF) cells. 
HEF cells were cultivated continuously from PD 40 with ascorbic acid and growth 
curve  was  prepared  as  described  in  “Materials  and  Methods”.  (A)  The  effect  of 
ascorbic acid on replicative life span of HEF cells. The treatments of ascorbic acid 
are as follows; untreated (◆), 2 μM ascorbic acid (▼), 20 μM ascorbic acid (▲), 
200 μM ascorbic acid (■). (B) The effect of ascorbic acid and hydrogen peroxide 
on replicative life span of HEF cells. HEF cells were treated continuously with 20 
μM hydrogen peroxide from PD 40. The treatments are as follows; 20 μM H2O2 
(◆), 2 μM ascorbic acid and 20μM H2O2 (▼), 20 μM ascorbic acid and 20 μM 
H2O2  (▲),  200  μM  ascorbic  acid  and  20  μM  H2O2 ( ■ ) .
and the filter was blocked in 5% nonfat powdered milk in TBST 
[50 mM Tris (pH 7.5), 150 mM NaCl, 0.1% Tween 20]. The 
blots were probed with anti-p21 monoclonal antibody (Pharmi-
gen), anti-p53 monoclonal antibody (DO-1, Santa Cruz), and anti- 
phospho-p53 (ser-15, Santa Cruz). The bands were visualized 
with the ECL kit according to manufacturer’s instruction 
(Amersham).
AP site assay
AP (apurinic/apyrimidinic) site assay was performed as pre-
viously described (Nakamura et al., 1998). HEF cells in 5 mM 
glucose/PBS were
  incubated with 3 mM ARP (aldehyde reactive 
probe) at 37℃ for 60 min. The resulting cells were then
  collected 
by centrifugation and washed twice with PBS. The genomic DNA 
was isolated by chloroform/phenol
  extraction. One microgram of 
DNA was
  dissolved in 200 µL of 10 mM Tris buffer (pH 9.0) 
and mixed with 15 µL of 5 M NaCl. The resulting mixture was 
incubated at room temperature for
  60 min with 30 µL of avidin- 
HRP. The DNA-avidin-HRP
  complex (DNA-HRP) was separated 
from unbound avidin-HRP by gently
  mixing 65 µL of 1 mM 
DAPER {N,N'-bis [3,3' (dimethylamino) propylamine-3,4,9,10- 
perylenetetracarboxylic diimide]} and incubated
  at room tem-
perature for 5 min. The DNA-DAPER precipitate was
  then 
collected by centrifugation at 4℃ at 12,500 × g for 5 min.
  The 
pellet was resuspended by pipetting into wash buffer [170 mM 
NaCl, 20 mM Tris (pH 8.0), 0.25% Tween 20, 1% BSA], 
followed
  by centrifugation at 4℃ at 12,500 × g for 5 min. DNA- 
HRP precipitate was suspended in ice-cold
  50 mM Na-citrate 
(pH 5.3) and sonicated for
  2-3 sec and cooled
  immediately. AP 
site formation was measured HRP activity, as an indicator of 
AP
  sites in DNA-HRP by using fluorogenic QuantaBlu substrate 
kits
  (Pierce). Average value and standard deviation calculated 
from more than three repeats of experiment were used.
Results
Ascorbic acid treatment extended replicative life span of HEF 
cells
In order to test whether ascorbic acid extends replicative life 
span of HEF, HEF cells were treated continuously with various 
concentrations of ascorbic acid from PD 40 and measured the 
maximum PD number. Cells were cultivated continuously in 
100-mm dishes by changing fresh media containing ascorbic acid 
once in every three days. Ascorbic acid treatment (at 200 µM) 
extended maximum population doubling of HEF cells by about 
18% (11 PD) (Fig. 1A). The treatment of 2 µM ascorbic acid 
extended maximum PD by 2-3.5 over the untreated control (Table 
1). High concentration of ascorbic acid, (higher than 2 mM) 
turned out to be toxic to the cells and led cells to death (data 
not shown). To confirm the effect of ascorbic acid, we also tested 
SA-β-gal staining, an in vitro and in vivo aging marker, at PD 
64. Senescent HEF cells have been known to show a marked 
increase of blue colored SA-β-gal staining in perinuclear area. 
As expected, HEF cells treated with ascorbic acid dramatically 
decreased SA-β-gal-positive staining compared to untreated-HEF 
cells or H2O2-treated HEF cells (Fig. 2A, B). Because hydrogen 
peroxide-treated HEF cells showed earlier replicative senescence 
than untreated HEF cells, we measured Rho123 at PD 58. HEF 
cells treated with 200 μM ascorbic acid lowered SA-β-gal 
positive staining by 2.3 folds staining and the treatment of cells 
with 2 μM decreased by about 20% in percentage of SA-β
-gal-stained cells. H2O2-treated HEF cells showed increased SA-β
-gal positive staining by about 10% as expected. The result 
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Fig. 2. The effect of ascorbic acid on SA-β-gal staining in HEF cells.
(A)  HEF  cells  were  seeded  at  an  initial  density  of  0.5 × 10
6/dish  at  PD  40  and 
cultivated  continuously  with  ascorbic  acid.  SA-β-gal  staining  was  performed  (a) 
untreated  old  HEF  cells  (PD  64)  (b)  untreated  young  HEF  cells  (P D  3 0 )  ( c )  H E F 
cells treated with 200 μM ascorbic acid (PD 64) (d) HEF cells treated with 20 μM 
hydrogen peroxide (PD 56). (B) The percentage of SA-β-gal positive cells. SA-β-gal 
staining was performed on ascorbic acid-treated HEF cells (PD 64), untreated old 
HEF cells (PD 64), and H 2O2-treated HEF cells (PD 58). The diagram was prepared 
f r o m  t h e  s t a i n i n g  r e s u l t .
Fig. 3. Analysis of DCFH oxidation for measuring cellular ROS level in ascorbic 
acid-treated HEF cells.
(A) Analysis of DCFH oxidation in ascorbic acid-treated HEF cells. HEF cells were 
treated  with  ascorbic  acid  beginning  from  PD  40.  Oxidation  of  DCFH  was 
determined at PD 64. (B) Analysis of DCFH oxidation in ascorbic acid/ H2O2-treated 
HEF cells. HEF cells were co-treated with 20 μM hydrogen peroxide and ascorbic 
acid  beginning  from  PD  40. 
Fig. 4. Analyses of Rho123 accumulation and aconitase activity as markers 
of mitochondrial function in ascorbic acid-treated HEF cells.
HEF cells were treated with ascorbic acid beginning from PD 40. Ascorbic acid- 
treated HEF cells were harvested at PD 64 and used for analysis. (A) Analysis of 
Rho123 accumulation in ascorbic acid-treated HEF cells. Accumulation of Rho123 
was determined as described in “Materials and Methods”. (B) Analysis of Rho123 
accumulation in ascorbic acid/ H2O2-treated HEF cells. HEF cells were co-treated 
with 20 μM hydrogen peroxide and ascorbic acid. Analysis of Rho123 accumulation 
was performed in old untreated HEF cells (PD 64) and H2O2-treated HEF cells (PD 
58). (C) Analysis of aconitase activity in ascorbic acid-treated HEF cells. Cell extracts 
were  promptly  assayed  for  aconitase  activity  as  described  in  “Materials  and 
Methods”.
life span in HEF cells.
Ascorbic acid treatment lowered ROS level in HEF cells
Since reactive oxygen species (ROS) known to damage 
progressively vital macromolecules and thereby contribute to the 
processes of aging and cancer formation, we measured cellular 
ROS levels by estimating the oxidation of DCFH in HEF cells. 
HEF cells were treated continuously with ascorbic acid from PD 
40. Cells were harvested at PD 64 and were used for ROS 
analysis. Cells treated with ascorbic acid exhibited much less 
ROS when compared with untreated HEF cells (Fig. 3A). HEF 
cells treated with 200, 20, and 2 μM ascorbic acid showed 5, 
3, and 3 relative fluorescence of ROS formation but untreated 
HEF cells showed about 20 relative fluorescence of ROS 
formation. The result indicates ascorbic acid lowered ROS level 
by 6.7 folds. Because hydrogen peroxide-treated HEF cells 
showed earlier replicative senescence than untreated HEF cells, 
we measured ROS formation at PD 58. The treatment of ascorbic 
acid dramatically decreased ROS even in H2O2-treated HEF cells 
(20  μM) (Fig. 3B).
Ascorbic acid treatment prevents age-dependent decline of 
mitochondrial function in HEF cells
Since ROS is known to be generated in mitochondria and 
mitochondria are the major target of ROS, we attempted to 
measure mitochondrial damage by analyzing Rho123. The 
Rho123 fluorescence that accumulated in HEF cells was mea-
sured by fluorometer. HEF cells were treated continuously with 
ascorbic acid from PD 40. Cells were harvested at PD 64 and 
were used for Rho123 analysis. Senescent HEF cells showed high Won-Sang Hwang et al. 109
Fig. 5. Cell cycle analysis of ascorbic acid-treated HEF cells.
Ascorbic acid-treated HEF cells were stained with propidium iodide and cell cycle 
was  determined  by  FACS  analysis.  Upper  panel  represents  the  results  of  FACS 
analysis and lower panel shows a plot prepared from above results. (A) Untreated 
old  HEF  cells  (PD  62),  (B)  H2O2-treated  old  HEF  cells  (PD  56),  (C)  ascorbic 
acid-treated HEF cells (2 μM, PD 62), (D) ascorbic acid-treated HEF cells (20 μM, 
PD  62),  (E)  ascorbic  acid-treated  HEF  cells  (200  μM,  PD  62).
Fig. 6. Western blot analysis of cell cycle marker proteins.
Ascorbic acid-treated HEF cells were harvested and cell extracts were prepared. 
Western  blot  analysis  was  performed  for  cell  extracts  using  specific  antibodies 
against  p21,  p53,  and  phospho-p53  at  ser  15.  β-actin  was  used  as  a  protein 
loading  control.  Lane  1;  untreated  old  HEF  cells  (PD  54),  lane  2;  ascorbic 
acid-treated HEF cells (200 μM, PD 54), lane 3; ascorbic acid-treated HEF cells 
( 2 0 0  μ M ,  P D  6 4 ) ,  la n e  4 ;  u n t r e a t e d  o ld  H E F  c e l ls  ( P D  6 4 ) ,  l a n e  5;  ascorbic 
acid-treated  HEF  cells  (200  μM,  PD  72).
accumulation of Rho123 while young HEF cells showed much 
less levels of Rho123, indicating that senescent HEF cells have 
much higher mitochondrial damage. Rho123 accumulation was 
decreased by 70, 67, and 60% when treated with 200 μM, 20 
μM, and 2 μM ascorbic acid, respectively (Fig. 4A). Because 
hydrogen peroxide-treated HEF cells showed earlier replicative 
senescence than untreated HEF cells, we measured Rho123 at 
PD 58. Hydrogen peroxide treatment exhibited much higher 
accumulation of Rho123 (by about 35%) as expected. Treatment 
of cells with ascorbic acid also lowered hydrogen peroxide- 
induced accumulation of Rho123 (Fig. 4B). Since age-dependent 
decline in aconitase activity as a marker of mitochondrial 
dysfunction was reported (Levine, 1997), we examined the effect 
of ascorbic acid on age-dependent decrease of aconitase activity. 
Ascorbic acid-treated HEF cells (at 200 μM) showed about 41% 
increases in aconitase activity when compared to untreated old 
HEF cells. These results suggest that ascorbic acid protects ag-
ainst age-dependent decline of mitochondrial function (Fig. 4C).
Ascorbic acid treatment relieved age dependent G1 arrest in HEF 
cells
Since senescent cells have known to show G1 arrest, we tested 
whether ascorbic acid treatment lowers senescence-dependent G1 
arrest. HEF cells were treated continuously with ascorbic acid 
from PD 40. Cells were harvested at PD 62 and were used for 
cell cycle analysis. Ascorbic acid treated-HEF cells (20 and 200 
μM) showed considerable decrease from 64% to 52% in G1 
population (Fig. 5). Further western blot analysis of cell cycle 
markers at HEF cells (old: PD 54, senescent: PD64) and ascorbic 
acid-treated HEF cells (old: PD 54, PD64, senescent: PD72) 
showed that ascorbic acid treatment markedly decreased the 
levels of p53, phospho-p53 at ser 15, and p21, indicating that 
ascorbic acid treatment relieved senescence-related G1 arrest 
(Fig. 6).
Ascorbic acid treatment decreased age dependent DNA damage 
in HEF cells
In order to examine whether ascorbic acid treatment reduces 
age dependent DNA damage, ascorbic acid-treated HEF cells 
were tested for AP site, a DNA base damage. HEF cells were 
treated continuously with ascorbic acid from PD 40. Cells were 
harvested at PD 64 and were used for AP site analysis. As 
expected, old HEF cells (PD 64) had about 68% higher AP sites 
compared to young HEF cells (PD 30). H2O2-treated HEF cells 
(PD 58) accumulated about 55% higher AP sites than untreated 
old HEF cells did. HEF cells treated with ascorbic acid decreased 
AP sites by 35% at 200 μM, by 13.7% at 20 μM, and by 9.8% 
at 2 μM when compared with untreated HEF cells (PD 64) (Fig. 
7). The result suggested that ascorbic acid treatment markedly 
decreased age dependent DNA damage.110 Ascorbic acid extends replicative life span
Fig. 7. Analysis of AP sites in ascorbic acid-treated HEF cells.
AP  site  were  determined  in  ascorbic  acid-treated  HEF  cells  as  described  under 
“Materials and Methods”. Samples were as follows; untreated-young HEF cells (PD 
30), untreated-old HEF cells (PD 64), ascorbic acid-treated old HEF cells (2, 20, 
and  200  μM  ascorbic  acid,  PD  64),  and  H2O2-treated  HEF  cells  (PD  58).
Discussion
Ascorbic acid has been reported to extend replicative life span 
in human diploid fibroblast culture. The extension of replicative 
life span was accompanied by reducing the rate of telomere 
shortening (Farriol et al., 1994; Kashino et al., 2003). However, 
the detailed molecular mechanism how ascorbic acid treatment 
extends replicative life span in human diploid fibroblast other 
than preventing telomere shortening has not been investigated. 
In this study, we attempted to elucidate molecular mechanism 
for the extension of replicative life span in HEF cells by ascorbic 
acid treatment. HEF cells were treated continuously with ascorbic 
acid from PD 40 untreated cells and harvested at PD 64 
(senescent state in untreated HEF cells) for analyses of ROS, 
mitochondrial damage, G1 population, and DNA damage. ROS 
level estimated by analyzing DCFH was decreased dramatically 
by ascorbic acid treatment. Mitochondrial function assessed by 
Rho123 accumulation and aconitase activity was increased up 
to about 2 folds by ascorbic acid treatment (Fig. 4A, B). DNA 
damage measured by AP sites was decreased remarkably by 
ascorbic acid treatment (Fig. 7). G1 population examined by flow 
cytometry and western blot analysis of G1 markers (p21, p53, 
phospho-p53) was decreased markedly by ascorbic acid treatment 
(Fig. 5, 6) (Kim et al., 2005). Our result suggests that ascorbic 
acid extends replicative life span of HEF cells possibly by 
increasing growing population of HEF cells through lowering 
cellular ROS level and thereby reducing mitochondrial and DNA 
damages.
We also tested the effect of hydrogen peroxide treatment in 
addition to ascorbic acid treatment, as an additional oxidative 
stress. 20 μM of hydrogen peroxide was continuously treated 
beginning from PD 40 of HEF cells. H2O2 treatment resulted 
in apparently a premature senescence due to additional oxidative 
stress. H2O2-treated HEF cells decreased replicative life span by 
6-8 PD compared to untreated HEF cells. Ascorbic acid treatment 
reversed this decrease induced by H2O2 treatment (Fig. 1). 
H2O2-treated HEF cells exhibited 13% higher SA-β-gal staining 
positive population as expected (Fig. 2). H2O2 treatment highly 
increased DCFH (60% increase) and Rho123 (40% increase) but 
ascorbic acid treatment reversed dramatically both DCFH and 
Rho123 to the level of H2O2-untreated HEF cells (Fig. 3, 4). AP 
sites were also increased greatly (55% increase) by H2O2 
treatment (Fig. 7). Overall, H2O2 treatment speeded up the 
accumulation of oxidative stress by providing additional cellular 
oxidative stress and thereby accelerated replicative senescence, 
confirming that oxidative stress is a genuine contributor to 
establish replicative senescence.
Reduction in the rate of telomere shortening by ascorbic acid 
treatment may also contribute to the extension of replicative life 
span of HEF cells as reported previously (Farriol et al., 1994; 
Kashino et al., 2003). However, telomere shortening appears to 
be a part of DNA damage since telomere shortening activates 
DNA damage checkpoints that block further cell replication 
(Smogorzewska & de Lange, 2002). Ascorbic acid scavenges 
ROS and thereby seems to relieve random attack of telomere 
by ROS. This implies that telomere shortening may be a part 
of oxidative stress. In this context, it is understandable that many 
stimuli, including DNA damage and oxidative stress, cause cells 
to arrest growth with a senescent phenotype, independently of 
telomere length (Hart & Setlow, 1974; Parrinello et al., 2003). 
In addition, other mammalian primary somatic cells like mouse 
and dog fibroblast cells are known to contain considerable 
telomerase activity and longer telomeres. Mouse fibroblast cells 
still undergo replicative senescence after a limited number of 
population doublings when cultured, even though telomere 
shortening does not happen. This indicates again that oxidative 
stress is much larger phenomenon than telomere shortening. DNA 
damage in other than telomere region and mitochondrial 
dysfunction resulted by ROS may also contribute greatly to 
establish replicative senescence. ROS formed in mitochondria 
during ATP generation is one of inevitable byproducts prepared 
whenever we inhale oxygen. Cultivation of fibroblast in lower 
oxygen, instead of atmospheric oxygen resulted in delaying of 
replicative senescence. MEFs cultured in atmospheric oxygen 
contained more DNA oxidative damages than those cultured in 
lower oxygen, indicating that oxidative stress contributes to 
replicative senescence (Parrinello et al., 2003). Ascorbic acid 
captures directly or indirectly ROS and thereby relieves various 
oxidative stresses such as mitochondrial dysfunction, DNA 
damage, and telomere shortening. This relief of oxidative stress 
seems to result in the extension of replicative life span in 
fibroblast cells. 
Why does ascorbic acid extend replicative life span of HEF 
cells only by 18% as shown in Fig. 2, even though ascorbic 
acid-treated HEF cells (PD 64) were similar to untreated young 
HEF cells (PD 30) rather than to untreated old HEF cells (PD 
64) in ROS formation, mitochondrial damage and function, and 
AP site formation. One possible explanation is that water soluble 
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cellular compartments. Other lipid soluble antioxidants like 
vitamin E may be necessary to have better efficiency in capturing 
ROS. However, this is not likely since co-treatment with ascorbic 
acid and vitamin E did not extend considerably replicative life 
span compared to treatment with ascorbic acid alone (data not 
shown). Another explanation is that intrinsic contributors that 
mediate partly replicative senescence but are not affected by 
oxidative stress appear to exist inside of cells. These intrinsic 
contributors will be deteriorated by cellular aging but not by 
oxidative stress. Therefore, although oxidative stress including 
changes in ROS level, mitochondrial damage and function, and 
AP site formation is relieved by antioxidants like ascorbic acid, 
intrinsic contributors that are not seriously related with oxidative 
stress but become less efficient during aging process will provide 
environment to cause replicative senescence. One possible 
intrinsic contributor will be cellular antioxidative enzymes and 
molecules like superoxide dismutase (SOD), catalase, peroxidase, 
glutathione, and so on. Although some of them are known to 
be activated by oxidative stress, their levels and activities are 
also reported to be decreased seriously during aging process. As 
we expected, age-related decrease in MnSOD and catalase 
activities in HEF cells have been reported (Li et al., 2006). The 
other possible intrinsic contributor will be DNA repairing system. 
Various DNA repairing activities have been reported to be 
diminished during aging process. Double strand break repair 
(DSBR) activity was decreased greatly during cellular senescence 
(Lombard et al., 2005; Vogel et al., 1999). Base excision repair 
(BER) activity was also known to be decreased seriously by aging 
process (Mostoslavsky et al., 2006). It is not clear yet that this 
reduction of DNA repairing activities during aging process is 
not related with oxidative stress. However, fibroblast cells 
obtained from long-lived mammals had longer replicative life 
span and generally higher DNA repair activities when compared 
to fibroblast cells obtained from short-lived mammals (data not 
shown, a manuscript is in preparation). There may be additional 
intrinsic contributors to help building up replicative senescence 
regardless of oxidative stress. On behalf of these intrinsic 
contributors, HEF cells still undergo replicative senescence, even 
though ascorbic acid extended somewhat their replicative life 
span by relieving oxidative stress. Replicative senescence is a 
complicated process that is mediated by various genetic and 
environmental contributors. Further detailed and systematical 
investigation will provide better understanding of replicative 
senescence by elucidating molecular mechanism.
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